Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2019
Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer
Ruoshi Shi, Nikolina Radulovich, Christine Ng, et al.
Plos Computational Biology
|
January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer
Deena M A Gendoo, Robert E Denroche, Amy Zhang, et al.
Cell
|
October 13, 2021
Spatially confined sub-tumor microenvironments in pancreatic cancer
Barbara T Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
Nature Communications
|
January 16, 2019
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
Yoshihito Kano, Teklab Gebregiworgis, Christopher B Marshall, et al.
Scientific Reports
|
May 20, 2021
Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers
Nhu-An Pham, Nikolina Radulovich, Emin Ibrahimov, et al.
Nature Communications
|
November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
Teklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Science Advances
|
September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability
Manuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion
Claudia Gentile, William W Feng, Sean M Lenahan, et al.
Nature Chemical Biology
|
February 26, 2020
A drug discovery platform to identify compounds that inhibit EGFR triple mutants
Punit Saraon, Jamie Snider, Yannis Kalaidzidis, et al.
Journal of Molecular Biology
|
October 18, 2021
Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells
Punit Saraon, Jamie Snider, Wiebke Schormann, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2019
Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer
Ruoshi Shi, Nikolina Radulovich, Christine Ng, et al.
Plos Computational Biology
|
January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer
Deena M A Gendoo, Robert E Denroche, Amy Zhang, et al.
Cell
|
October 13, 2021
Spatially confined sub-tumor microenvironments in pancreatic cancer
Barbara T Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
Nature Communications
|
January 16, 2019
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
Yoshihito Kano, Teklab Gebregiworgis, Christopher B Marshall, et al.
Scientific Reports
|
May 20, 2021
Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers
Nhu-An Pham, Nikolina Radulovich, Emin Ibrahimov, et al.
Nature Communications
|
November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
Teklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Science Advances
|
September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability
Manuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion
Claudia Gentile, William W Feng, Sean M Lenahan, et al.
Nature Chemical Biology
|
February 26, 2020
A drug discovery platform to identify compounds that inhibit EGFR triple mutants
Punit Saraon, Jamie Snider, Yannis Kalaidzidis, et al.
Journal of Molecular Biology
|
October 18, 2021
Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells
Punit Saraon, Jamie Snider, Wiebke Schormann, et al.
Page
of 4